Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million | The Motley Fool

This Boulder-based biotech, developing targeted cancer therapies, reported a notable insider sale as Phase 1 trials advance for key drug candidates.

By Vivid Griffin · March 28, 2026 · 1 min read

Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million | The Motley Fool

Source: The Motley Fool

This Boulder-based biotech, developing targeted cancer therapies, reported a notable insider sale as Phase 1 trials advance for key drug candidates.

Related Posts

Is LXP Industrial Trust a Buy or Sell After Pensionfund PDN Dumped Shares Worth $6.4 Million?

by Steel Nova · Mar 28, 2026

#lxp #660899dd-051f-4666-b0af-d9e2f01a92dc #coveragefilings
The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M | The Motley Fool

by Rogue Orion · Mar 28, 2026

#lqda #af6b2d59-c8cb-4962-b9c0-b9ab094c20ff #coveragefilings
Five9 President's Share Sale Was Half Tax Bill, Half Trading Plan — Not a Red Flag

by Deep Scout · Mar 28, 2026

#fivn #6440f39d-ca5e-45d4-be2a-34d7b5f1d346 #coveragefilings
10 Percent Owners Sell 2.5 Million V2X Shares For Aroun | The Motley Fool

by Deep Scout · Mar 28, 2026

#vvx #97a2567d-b369-43a9-8614-19b9a006aa3a #coveragefilings
A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K

by Deep Scout · Mar 28, 2026

#lmat #653e6a49-510d-4920-ac44-93cf2b6cfd4a #coveragefilings

Trending on ShareHub

Latest on ShareHub

Browse Topics

#artificial intelligence (5113)#deep learning (3221)#pro graphics (2571)#ai (1906)#generative ai (1655)#3d (1638)#news (1638)#gaming (1634)#geforce now (1192)#cloud gaming (1161)

Around the Network